The first product launch for
Seqirus, formerly bioCSL (PD 10
Nov), is Caldolor, an intravenous
formulation of non-steroidal
anti-inflammatory drug ibuprofen,
registered for the management of
post-operative pain and reduction
of fever in adults.
It is designed primarily for
patients in the hospital setting
undergoing surgery and who
require ongoing IV analgesia.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Nov 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.